BlackRock’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.98M Buy
1,289,550
+22,047
+2% +$104K ﹤0.01% 3573
2025
Q4
$6.12M Buy
1,267,503
+759,503
+150% +$2.54M ﹤0.01% 3754
2025
Q3
$1.02M Hold
508,000
﹤0.01% 4279
2025
Q2
$305K Sell
508,000
-58,905
-10% -$30.2K ﹤0.01% 4570
2025
Q1
$153K Sell
566,905
-26,421
-4% -$8.76K ﹤0.01% 4657
2024
Q4
$309K Buy
593,326
+25,446
+4% +$62.1K ﹤0.01% 4536
2024
Q3
$1.84M Sell
567,880
-5,434
-0.9% -$17.6K ﹤0.01% 4023
2024
Q2
$1.72M Sell
573,314
-4,874
-0.8% -$17.6K ﹤0.01% 4007
2024
Q1
$2.69M Buy
578,188
+5,445
+1% +$26.2K ﹤0.01% 3894
2023
Q4
$2.37M Sell
572,743
-1,364
-0.2% -$4.04K ﹤0.01% 3978
2023
Q3
$1.72M Sell
574,107
-31,147
-5% -$92.5K ﹤0.01% 4057
2023
Q2
$1.49M Sell
605,254
-1,233,163
-67% -$3.41M ﹤0.01% 4171
2023
Q1
$4.15M Sell
1,838,417
-24,725
-1% -$85.3K ﹤0.01% 3711
2022
Q4
$6.5M Sell
1,863,142
-290,186
-13% -$2.55M ﹤0.01% 3600
2022
Q3
$79.7M Buy
2,153,328
+417
+0% +$11.6K ﹤0.01% 2114
2022
Q2
$40.9M Buy
2,152,911
+200,103
+10% +$4.36M ﹤0.01% 2627
2022
Q1
$52.7M Buy
1,952,808
+567,573
+41% +$11.7M ﹤0.01% 2553
2021
Q4
$31.2M Buy
1,385,235
+174,994
+14% +$3.89M ﹤0.01% 2996
2021
Q3
$31.7M Sell
1,210,241
-259,866
-18% -$6.96M ﹤0.01% 2967
2021
Q2
$47.1M Sell
1,470,107
-18,068
-1% -$628K ﹤0.01% 2741
2021
Q1
$52.4M Sell
1,488,175
-4,844
-0.3% -$169K ﹤0.01% 2583
2020
Q4
$47.9M Buy
1,493,019
+280,318
+23% +$9.63M ﹤0.01% 2502
2020
Q3
$45.6M Sell
1,212,701
-4,064
-0.3% -$157K ﹤0.01% 2359
2020
Q2
$54.4M Buy
1,216,765
+738,752
+155% +$31.2M ﹤0.01% 2199
2020
Q1
$16.3M Buy
478,013
+334,900
+234% +$13.5M ﹤0.01% 2711
2019
Q4
$5.58M Buy
+143,113
New +$4.35M ﹤0.01% 3470

Other funds holding RLMD